EUVIMEDEUVIMED entdecken
Crossref

Adverse Drug Reactions Associated with Polypharmacy in Elderly Patients

European Journal of Clinical Pharmacy · 25.10.2025 · 7 (1) · 9379-9384

DOI: 10.61336/ejcp/25-08-669 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Clinical Pharmacy, online erschienen am 25.10.2025.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chronic conditions that need long-term treatment are a common problem in elderly patients and lead to the high prevalence of polypharmacy. Medication safety remains a major challenge in geriatric care, as the use of multiple medications increases the risk of adverse drug reactions (ADRs), drug drug interactions, hospitalization, and mortality.

Objective

The study aimed to determine the frequency and patterns of adverse drug reactions (ADRs) associated with polypharmacy among elderly patients and to identify factors contributing to the occurrence of ADRs.Methodology: This was a cross sectional study carried out in the Department of Medicine Khyber Teaching Hospital, Peshawar from jan 2025 to june 2025. over a period of six months. Patients were recruited consecutively into the study to make up 100 elderly patients (aged ≥65 years) taking 5 or more medicines. A structured proforma was used to record demographic data, comorbidities, medication profiles and ADRs. The medications were identified as causing ADRs by clinical assessment and medication review. The analysis of the data was carried out using SPSS 26. The quantitative variables were presented in the form of mean and standard deviation, and qualitative variables were presented as frequencies and percentages. A p-value < 0.05 was deemed significant.

Results

The 100 participants, 58% were male and 42% were female. The mean age was 72.4 ± 6.8 years. Polypharmacy (5–9 medications) was observed in 67% of patients, while 33% had hyper polypharmacy (≥10 medications). ADRs were identified in 38% of patients. The most common ADRs included dizziness (26.3%), gastrointestinal disturbances (21.1%), hypotension (18.4%), hypoglycemia (13.2%), and renal dysfunction (10.5%). Patients with ADRs had a significantly higher mean number of prescribed medications than those without ADRs (9.2 ± 2.1 vs. 6.7 ± 1.8; p=0.002). Hyper polypharmacy (p=0.01) and multiple comorbidities (p=0.03) were significantly associated with ADR occurrence.

Conclusion

Polypharmacy is associated with adverse drug reactions in elderly people. Risk of ADR is very high with multiple comorbidities and high medication burden. Medication rational prescribing and routine review of medications are vital to enhance medication safety and minimise preventable drug-related complications.

Zitieren

APA

(2025). Adverse Drug Reactions Associated with Polypharmacy in Elderly Patients. European Journal of Clinical Pharmacy, 7(1), 9379-9384. https://doi.org/10.61336/ejcp/25-08-669

Vancouver

Adverse Drug Reactions Associated with Polypharmacy in Elderly Patients. European Journal of Clinical Pharmacy. 2025;7(1):9379-9384. doi:10.61336/ejcp/25-08-669

BibTeX
@article{euvimed2025,
  title = {Adverse Drug Reactions Associated with Polypharmacy in Elderly Patients},
  journal = {European Journal of Clinical Pharmacy},
  year = {2025},
  volume = {7},
  number = {1},
  pages = {9379--9384},
  doi = {10.61336/ejcp/25-08-669}
}
Kostenlos starten →